PEVION BIOTECH LTD has a total of 53 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are NORDEN LAB INC, AMBICO INC and STICKL HELMUT.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 14 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Canada | 6 | |
#4 | United States | 6 | |
#5 | Australia | 5 | |
#6 | South Africa | 5 | |
#7 | China | 3 | |
#8 | EAPO (Eurasian Patent Organization) | 3 | |
#9 | Brazil | 2 | |
#10 | Norway | 1 | |
#11 | Poland | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines | |
#4 | Environmental technology | |
#5 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Zurbriggen Rinaldo | 45 |
#2 | Rasi Silvia | 14 |
#3 | Amacker Mario | 10 |
#4 | Brunner Josef | 8 |
#5 | Vadrucci Sonja | 7 |
#6 | Pluschke Gerd | 6 |
#7 | Kammer Andreas | 6 |
#8 | Robinson John | 6 |
#9 | Cassone Antonio | 4 |
#10 | Rinaldo Zurbriggen | 4 |
Publication | Filing date | Title |
---|---|---|
EP2292258A1 | Multiepitope vaccine for Her2/neu-associated cancers | |
EP1797895A1 | An adjuvant system comprising virosomes and liposomes | |
EP1676859A1 | Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide | |
EP1676569A1 | Lyophilization of virosomes | |
EP1599225A2 | Compositions and methods for the generation of protective immune response against malaria | |
BR0316402A | fusogenic vesicle, methods for preparing an encapsulating fusogenic vesicle, and for encapsulating at least one therapeutic or immunologically active substance in a fusogenic vesicle, use of a fusogenic vesicle, and, pharmaceutical formulation | |
US7378495B2 | PTH-rP related peptide cancer therapeutics | |
EP1484336A1 | Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines |